680
Participants
Start Date
March 31, 2007
Primary Completion Date
December 31, 2007
Study Completion Date
December 31, 2007
ceftaroline
600 mg parenteral infused over 60 minutes, every 12 hours for 5 to 14 days
vancomycin plus aztreonam
vancomycin at 1 g parenteral infused over 60 minutes followed by aztreonam 1 g infused over 60 minutes, every 12 hours, for 5 to 14 days.
Placebo
Ceftaroline fosamil 600 mg administered intravenously over 60 minutes every 12 hours, followed by placebo administered over 60 minutes every 12 hours.
Investigational Site, Sankt Pölten
Investigational Site, Graz
Investigational Site, Baltimore
Investigational Site, Marietta
Investigational Site, Columbus
Investigational Site, Atlantis
Investigational Site, Toledo
Investigational Site, Dortmund
Investigational Site, Guadalajara
Investigational Site, Seattle Zapopan
Investigational Site, Milwaukee
Investigational Site, Minneapolis
Investigational Site, Butte
Investigational Site, Kharkiv
Investigational Site, Springfield
Investigational Site, Wiesbaden
Investigational Site, Zaporizhya
Investigational Site, Lviv
Investigational Site, Los Angeles
Investigational Site, Buena Park
Investigational Site, Hawaiian Gardens
Investigational Site, Pasadena
Investigational Site, San Diego
Investigational Site, San Jose
Investigational Site, Tacoma
Investigational Site, Moscow
Investigational Site, Moscow
Investigational Site, Moscow Region
Investigational Site, Saint Petersburg
Investigational Site, Somers Point
Investigational Site, Buenos Aires
Investigational Site, Córdoba
Investigational Site, Santa Fe
Investigational Site, Braunau am Inn
Investigational Site, Sao Paula
Investigational Site, Temuco
Investigational Site, Valdivia
Investigational Site, Saint Petersburg
Investigational Site, Cottbus
Investigational Site, Homburg/Saar
Investigational Site, Mainz
Investigational Site, Riga
Investigational Site, Bielsko-Biala
Investigational Site, Krakow
Investigational Site, Krakow
Investigational Site, Lodz
Investigational Site, Lublin
Investigational Site, Poznan
Investigational Site, Warsaw
Investigational Site, Warsaw
Investigational Site, Wroclaw
Investigational Site, Kyiv
Investigational Site, London
Investigational Site, London
Lead Sponsor
Forest Laboratories
INDUSTRY